 |
Video: What is a Stock Split?
|
 |
Second Sight Medical Products develops, manufactures and markets implantable visual prosthetics that deliver artificial vision to blind individuals. Co. is developing the Orion® Visual Cortical Prosthesis System, an implanted cortical stimulation device which provides artificial vision to individuals who are blind due to a range of causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease and eye injury. Co.'s commercially approved product, the Argus® II Retinal Prosthesis System, treats outer retinal degenerations, such as retinitis pigmentosa, a hereditary disease that causes a progressive degeneration of the light-sensitive cells of the retina. According to our EYES split history records, EYES has had 2 splits. | |
 |

EYES (EYES) has 2 splits in our EYES split history database. The first split for EYES took place on January 06, 2020. This was a 1 for 8 reverse split, meaning for each 8 shares of EYES owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split. EYES's second split took place on August 19, 2022. This was a 1 for 3 reverse split, meaning for each 3 shares of EYES owned pre-split, the shareholder now owned 1 share. For example, a 125 share position pre-split, became a 41.6666666666667 share position following the split.
When a company such as EYES conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the EYES split history from start to finish, an original position size of 1000 shares would have turned into 41.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into EYES shares, starting with a $10,000 purchase of EYES, presented on a split-history-adjusted basis factoring in the complete EYES split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/20/2015 |
|
End date: |
08/30/2022 |
|
Start price/share: |
$210.00 |
|
End price/share: |
$4.14 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.03% |
|
Average Annual Total Return: |
-40.65% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$197.13 |
|
Years: |
7.53 |
|
|
 |
Date |
Ratio |
01/06/2020 | 1 for 8 | 08/19/2022 | 1 for 3 |
|
 |